How to Use the USP–NF Errata Table

Row 16 of Column 4 of Table 1: Change
70
to:
100
AND
Row 16 of Column 5 of Table 1: Change
25
to:
10

Rows 11 and 15 of Column 2 of Table 2: Change
100
to:
10
AND
Rows 11 and 15 of Column 3 of Table 2: Change
10
to:
1.0
AND
Row 11 of Column 4 of Table 2: Change
1.5
to:
0.15
AND
Row 15 of Column 4 of Table 2: Change
30
to:
3.0

Row 13 of Column 4 of Table 2: Change
25
to:
1.0

Line 2 of Target Elements: Change
Pd
to:
Pb

In the Note in line 11 of Titration: Change
Rinse the grains by swirling with three 15-mL portions of Purified Water, and add the washings to the main solution.
to:
Rinse the grains by swirling with three 15-mL portions of Carbon Dioxide-Free Water, and add the washings to the main solution.

Line 8 of Analysis: Change
Include in each rack 1–2 control tubes containing 1 mL of the inoculum medium (see Table 8) but no antibiotic.
to:
Include in each rack 1–2 control tubes containing 1 mL of the test diluent (see Table 7) but no antibiotic.

Line 19: Change
25C(A_U/A_S)

to:
250C(A_U/A_S)

Line 1:
Delete
NMT 0.1%

Change the subsection

Buffer and Diluent: Prepare as directed in the Assay.

to:

Diluent: Prepare as directed in the Assay.

Buffer: 6.8 g/L of monobasic potassium phosphate in
water. Adjust with phosphoric acid to a pH of 3.0.

Line 1 of Test preparation: Change
Use the Assay preparation, prepared as directed in the Assay.
to:
Transfer about 69 mg of Aminosalicylate Sodium, accurately weighed, to a 100-mL low-actinic volumetric flask, add 50 mL of Mobile phase, and swirl to dissolve. Add 10.0 mL of Internal standard solution, dilute with Mobile phase to volume, and mix.

Line 2: Change text of Sample solution from
10.0 mg/mL
to:
10.0 mg/mL of ampicillin

Line 1 of Test preparation: Change
Warm 1.3 g with 3 mL of 3 N hydrochloric acid to completely dissolve.

to:
Warm 1.3 g with 3 mL of 3 N hydrochloric acid until no more dissolves.

Line 9 of Procedure: Change
R_U and R_S are as defined therein.
to:
R_U and R_S are the peak area ratios of atropine to homatropine.

Line 1 of Buffer: Change
3.5 g/mL
to:
3.5 g/L

Line 5 of Analysis: Change
Result = (r_U/r_S) × (C_S/C_U) × P × F × 100
to:
Result = (r_U/r_S) × (C_S/C_U) × P × 100

Line 2: Change
8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-, endo-, methanesulfonate;
to:
8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-N-methyl-, endo-, methanesulfonate;

Line 15 of Procedure: Change
relative retention time greater than 6.
to:
relative retention greater than 6.

Line 5 of Titrimetric system: Delete the subsection
Blank: 100 mL of water and 4 mL of 3 N hydrochloric
acid

AND
Line 11 of Analysis: Delete the sentence

Perform a blank determination.

AND
Line 13 of Analysis: Change

Result = [(V − B) × N × F × 100]/W
to:

Result = [(V × N × F)/W] × 100

AND
Line 15 of Analysis: Delete

B = volume of titrant consumed by the Blank (mL)

Line 1 of Mobile phase: Change
Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid.

to:
Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas.

Line 5: At end of USP Reference Standards, add
USP Meprobamate RS

Line 5 of Chromatographic system: Change
Column: 4.0-mm x 25-cm; 5-µm packing L##¹
to:
Column: 4.0-mm x 25-cm; 5-µm packing L76
AND
Delete corresponding footnote: "Available as Metrosep C4-250."

Line 6 of Sample solution: Change
Pipet 2.5 mL of the Sample solution
to:
Pipet 2.5 mL of the sample

Line 1 of Aqueous potassium hydroxide solution: Change
Dissolve 800 mg of potassium hydroxide in 1000 mL of freshly boiled water, mix, and cool.
to:
Dissolve 800 g of potassium hydroxide in 1000 mL of freshly boiled water, mix, and cool.